Venetoclax resistance induced by activated T cells can be counteracted by sphingosine kinase inhibitors in chronic lymphocytic leukemia.
Sarapura Martinez VJ, Buonincontro B, Cassarino C, Bernatowiez J, Colado A, Cordini G, Custidiano MDR, Mahuad C, Pavlovsky MA, Bezares RF, Favale NO, Vermeulen M, Borge M, Giordano M, Gamberale R.
Sarapura Martinez VJ, et al. Among authors: favale no.
Front Oncol. 2023 Mar 20;13:1143881. doi: 10.3389/fonc.2023.1143881. eCollection 2023.
Front Oncol. 2023.
PMID: 37020867
Free PMC article.